Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 11:01 PM ET

Life Sciences Tools and Services

Company Overview of Cancer Research Institute, Inc.

Company Overview

Cancer Research Institute, Inc. engages in the support and coordination of scientific and clinical efforts that lead to the immunological treatment, control, and prevention of cancer. It specializes in immunology and cancer immunology research in the United States and internationally. The company provides cancer research programs, such as laboratory investigation and training programs, and clinical investigation programs; educational programs; public information programs; and conferences and meetings. It supports graduate students and postdoctoral fellows, as well as heads of university departments, hospitals, and clinics. Cancer Research Institute, Inc. was formerly known as New York Cancer...

55 Broadway

One Exchange Plaza

Suite 1802

New York, NY 10006

United States

Founded in 1953

Phone:

212-688-7515

Fax:

212-832-9376

Key Executives for Cancer Research Institute, Inc.

Chief Executive Officer and Director of Scientific Affairs
President and Trustee Emeritus
Co-Founder
Co-Founder and Trustee Emeritus
Chief Financial Officer and Director of Human Resources
Compensation as of Fiscal Year 2015.

Cancer Research Institute, Inc. Key Developments

CureVac Collaborates with the Cancer Research Institute and Ludwig Cancer Research to Enable Clinical Testing of Novel Immunotherapy Treatment Options for Cancer

Cancer Research Institute (CRI) and Ludwig Cancer Research (Ludwig), and CureVac, announced that they will collaborate to enable clinical testing of novel cancer immunotherapy treatment options. Amplifying the immune system's ability to recognize, attack, and destroy cancer, is a therapeutic strategy that recent studies have demonstrated to be a potent and effective approach to treatment of some cancers. Product approvals and promising clinical data for various checkpoint inhibitors, which block proteins responsible for immune system inhibition, support the potential of combining CureVac's RNActive(R) vaccines with this new class of treatment to significantly improve cancer patient survival. Ludwig and CRI will conduct up to five clinical studies of cancer immunotherapy combinations through their jointly coordinated CVC Trials Network using CureVac's investigational clinical stage drug, CV9202, combined with other priority agents available to CRI and Ludwig from their internal portfolios or accessed through additional industry partnerships. CV9202 contains NSCLC-associated antigens and is the optimized successor of CV9201, which has successfully completed a phase I/IIa clinical trial demonstrating its safety and immunogenicity. Additional investigational clinical stage drugs from CureVac's product pipeline can be added.

Similar Private Companies By Industry

Company Name Region
Sarah Cannon Research Institute, LLC United States
Aureon Biosciences, Inc. United States
ASL Analytical, Inc. United States
Cellective BioTherapy, Inc. United States
Huxley Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cancer Research Institute, Inc., please visit www.cancerresearch.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.